AllianzIM U.S. Equity Buffer20 Nov ETF (BATS:NVBW – Get Free Report) was the recipient of a large decrease in short interest during the month of October. As of October 15th, there was short interest totaling 112 shares, a decrease of 35.6% from the September 30th total of 174 shares. Based on an average daily volume of 3,346 shares, the days-to-cover ratio is presently 0.0 days. Currently, 0.0% of the shares of the company are short sold.
AllianzIM U.S. Equity Buffer20 Nov ETF Stock Performance
Shares of BATS NVBW opened at $36.92 on Monday. The firm has a 50 day moving average of $36.61 and a 200 day moving average of $35.25. The firm has a market capitalization of $97.84 million, a price-to-earnings ratio of 24.91 and a beta of 0.40. AllianzIM U.S. Equity Buffer20 Nov ETF has a 12-month low of $32.83 and a 12-month high of $37.22.
Institutional Trading of AllianzIM U.S. Equity Buffer20 Nov ETF
An institutional investor recently bought a new position in AllianzIM U.S. Equity Buffer20 Nov ETF stock. Blue Bell Private Wealth Management LLC acquired a new stake in shares of AllianzIM U.S. Equity Buffer20 Nov ETF (BATS:NVBW – Free Report) during the third quarter, according to its most recent disclosure with the SEC. The fund acquired 1,996 shares of the company’s stock, valued at approximately $73,000. Blue Bell Private Wealth Management LLC owned approximately 0.08% of AllianzIM U.S. Equity Buffer20 Nov ETF as of its most recent SEC filing.
About AllianzIM U.S. Equity Buffer20 Nov ETF
The Allianzim U.S. Large Cap Buffer20 Nov ETF (NVBW) is an exchange-traded fund that is based on the S&P 500 index. The fund aims for specific buffered losses and capped gains on the S&P 500 over a specific holdings period. The actively-managed fund holds options and collateral. NVBW was launched on Oct 31, 2022 and is managed by Allianz.
Recommended Stories
- Five stocks we like better than AllianzIM U.S. Equity Buffer20 Nov ETF
- Marvell Eyes a Swing for the AI Networking Fences as Markets Weigh Lumentum Price Tag
- Exxon’s Refining Profits Soared—Did Chevron Get the Same Windfall?
- Eli Lilly’s First Full Medicare Quarter: Is Volume Still Outrunning Price Cuts?
- Oracle’s AI Spending Peak Is in Sight—Can the Stock Recover?
Receive News & Ratings for AllianzIM U.S. Equity Buffer20 Nov ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AllianzIM U.S. Equity Buffer20 Nov ETF and related companies with MarketBeat.com's FREE daily email newsletter.
